Donald Trump Jr. is joining the board of prescription access platform BlinkRx, following 1789 Capital’s $140 million investment in the startup — making it the latest board the first son has joined since the election, NYNext has learned.
Rather than take a job in his father’s administration, Trump Jr. has doubled down on his private sector presence. Since November, he has joined Omeed Malik’s 1789 Capital as well as the boards of e-commerce platform PublicSquare and firearms retailer Grab-a-Gun, The Post previously reported.
Trump Jr. and Malik told NYNext they are focused on solving many of the same problems government is working on, like making healthcare more affordable and encouraging technologic innovation, but doing so with private-sector solutions.
“1789 invests in innovative technologies in areas of the economy, like education and healthcare, where excessive government involvement has actually led to poor outcomes and higher costs,” Malik said. “Our portfolio companies seek to rectify those problems using the free market.”
“It’s outrageous that hardworking Americans can’t get the medications they need,” Trump Jr. told NYNext. “BlinkRx has built the most advanced technology and business model to fix this broken system. I’m fully committed to doing everything in my power to ensure every single American has access to the medicine they deserve. This isn’t just a business — it’s a mission to solve one of healthcare’s biggest failures using entrepreneurship and innovation.”
The move comes as BlinkRx looks to expand its efforts to provide low-cost prescription medication delivery and support for patients across the United States, and as the Health and Human Services department weighs possible partnerships with the private sector. Malik and Trump Jr. are close with Robert F. Kennedy Jr. and were instrumental in bringing him into the MAGA fold.
“We are hopeful that all these incoming administration members are focused on innovation and using that to solve problems. We are excited to work with them and every other stakeholder,” BlinkRx CEO Geoff Chaiken told NYNext.
According to a BlinkRx spokesperson, its users save an average of $70 per prescription. The online pharmacy helps patients access medications at lower prices by working directly with pharmaceutical manufacturers and analyzing insurance costs to find the most affordable options. Sources told NYNext the company is expected to go public in the next two years.
“There is so much friction in getting prescriptions. You don’t know if it’s in stock, how much it will cost or if you can get it at a lower price,” Chaiken added. “BlinkRx connects all the stakeholders in the ecosystem so you know the lowest price after the prescription is written for you, and we facilitate the delivery at home.”
Malik and Trump have become significant investors in the “parallel economy,” capitalizing on opportunities skipped over by woke investors who prioritize companies promoting environmental, social and governance issues, known as ESG investing. Instead, Malik has coined the shorthand EIG — entrepreneurship, innovation and growth — to characterize 1789 Capital’s priorities.
Trump Jr.’s involvement with BlinkRx not only serves as a stamp of approval from the MAGA crowd but also shows how the parallel economy is expanding to touch every sector.
Malik took conservative e-commerce company PublicSquare public via a special purpose acquisition company in 2023. He’s since expanded the investment portfolio to include firearms, Tucker Carlson’s media network, rocket-engine manufacturer Firehawk and newsletter platform Substack.
1789 led the company’s most recent $140 million funding round that closed in November and included Joe Lonsdale’s 8VC, Fidelity Investments, Paul Allen’s family office Cercano Management and Sweetwater Private Equity — and received the boat seat that Trump Jr. is filling in return.
Malik co-founded 1789 Capital — named for the year the Bill of Rights was adopted — with Chris Buskirk who launched conservative advocacy group Rockbridge Network with JD Vance. The firm raised more than $150 million from GOP mega-donor Rebekah Mercer, who helped back news site Breitbart, research firm Cambridge Analytica and former Arizona Senate candidate Blake Masters.
